Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Pediatrics|June 23, 2010
Severe ulcerative colitis after rituximab therapyDaniela S Ardelean, Tanja Gonska, Shannon Wires, et al.Transplantation|July 29, 2004
Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative diseaseJackson Y Wong, Brian Tait, Bronwyn Levvey, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 17, 2004
Donor history of asthma is not a contraindication to lung transplantation: 12-year single-center experienceTakahiro Oto, Anne Griffiths, Bronwyn Levvey, et al.Journal of Crohn'S & Colitis|March 13, 2012
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel diseaseAlessandro Armuzzi, Gert Van Assche, Walter Reinisch, et al.Journal of Pediatric Gastroenterology and Nutrition|January 13, 2016
Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: A Propensity Score AnalysisSapir Choshen, Helen Finnamore, Marcus K H Auth, et al.Inflammatory Bowel Diseases|November 7, 2013
Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 studyOmoniyi J Adedokun, Zhenhua Xu, Lakshmi Padgett, et al.Inflammatory Bowel Diseases|March 4, 2015
Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's diseaseDavid Kevans, Williams Turpin, Karen Madsen, et al.Journal of Crohn'S & Colitis|May 26, 2021
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 StudyJoel R Rosh, Dan Turner, Anne Griffiths, et al.Clinical Transplants|July 22, 2008
The Alfred Hospital lung transplant experienceGregory I Snell, Donald S Esmore, Glen P Westall, et al.Inflammatory Bowel Diseases|November 16, 2017
Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical BenefitJeffrey S Hyams, Daphne Chan, Omoniyi J Adedokun, et al.Pageof 10